These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 26412063)

  • 1. Brain Functional Effects of Psychopharmacological Treatments in Schizophrenia: A Network-based Functional Perspective Beyond Neurotransmitter Systems.
    De Rossi P; Chiapponi C; Spalletta G
    Curr Neuropharmacol; 2015; 13(4):435-44. PubMed ID: 26412063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs.
    Binder EB; Kinkead B; Owens MJ; Nemeroff CB
    Biol Psychiatry; 2001 Dec; 50(11):856-72. PubMed ID: 11743941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimaging markers of antipsychotic treatment response in schizophrenia: An overview of magnetic resonance imaging studies.
    Tarcijonas G; Sarpal DK
    Neurobiol Dis; 2019 Nov; 131():104209. PubMed ID: 29953933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Structural Effects of Antipsychotic Treatment in Schizophrenia: A Systematic Review.
    Roiz-Santiañez R; Suarez-Pinilla P; Crespo-Facorro B
    Curr Neuropharmacol; 2015; 13(4):422-34. PubMed ID: 26412062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotransmitter interactions as a target of drug action.
    Potter WZ; Hsiao JK; Agren H
    Psychopharmacol Ser; 1989; 7():40-51. PubMed ID: 2574455
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronopharmacology of psychotropic drugs: circadian rhythms in drug effects and its implications to rhythms in the brain.
    Nagayama H
    Pharmacol Ther; 1993; 59(1):31-54. PubMed ID: 7903122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin in antipsychotic drugs action.
    Amato D
    Behav Brain Res; 2015 Jan; 277():125-35. PubMed ID: 25078293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New psychoactive drugs.
    Murray JB
    Genet Soc Gen Psychol Monogr; 1985 Nov; 111(4):429-53. PubMed ID: 2873081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional neuroimaging findings associated with the use of clozapine in schizophrenia: a systematic review.
    Garcia GJ; Chagas MH; Silva CH; Machado-de-Sousa JP; Crippa JA; Hallak JE
    Braz J Psychiatry; 2015; 37(1):71-9. PubMed ID: 25806554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term effects of antipsychotic treatment on cerebral function in drug-naive first-episode schizophrenia revealed by "resting state" functional magnetic resonance imaging.
    Lui S; Li T; Deng W; Jiang L; Wu Q; Tang H; Yue Q; Huang X; Chan RC; Collier DA; Meda SA; Pearlson G; Mechelli A; Sweeney JA; Gong Q
    Arch Gen Psychiatry; 2010 Aug; 67(8):783-92. PubMed ID: 20679586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional neuroimaging in schizophrenia: diagnosis and drug discovery.
    McGuire P; Howes OD; Stone J; Fusar-Poli P
    Trends Pharmacol Sci; 2008 Feb; 29(2):91-8. PubMed ID: 18187211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pursuing the actions of psychotropic drugs: receptor sites and endogenous cerebral programmes.
    McIlwain H
    Psychol Med; 1980 Aug; 10(3):399-402. PubMed ID: 6108586
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychotropic drug interactions. The first annual Thomas W. Quinn lecture in anesthesia.
    Trieger N
    Anesth Prog; 1981; 28(6):151-6. PubMed ID: 6123284
    [No Abstract]   [Full Text] [Related]  

  • 15. What do ERPs and ERFs reveal about the effect of antipsychotic treatment on cognition in schizophrenia?
    Korostenskaja M; Kähkönen S
    Curr Pharm Des; 2009; 15(22):2573-93. PubMed ID: 19689329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A perspective: psychopharmacological aspects of aggression in animals and man.
    Singhal RL; Telner JI
    Psychiatr J Univ Ott; 1983 Sep; 8(3):145-53. PubMed ID: 6139834
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurotransmitter interactions in psychotropic drug action: beyond dopamine and serotonin.
    Greenshaw AJ
    J Psychiatry Neurosci; 2003 Jul; 28(4):247-50. PubMed ID: 12921219
    [No Abstract]   [Full Text] [Related]  

  • 18. "Domain gauges": A reference system for multivariate profiling of brain fMRI activation patterns induced by psychoactive drugs in rats.
    Bruns A; Mueggler T; Künnecke B; Risterucci C; Prinssen EP; Wettstein JG; von Kienlin M
    Neuroimage; 2015 May; 112():70-85. PubMed ID: 25724758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.
    Wiesel FA
    Br J Psychiatry Suppl; 1994 Apr; (23):65-70. PubMed ID: 7913610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of psychotropic drugs on neurotransmitters in man.
    Potter WZ; Rudorfer MV; Pickar D; Linnoila M
    Life Sci; 1987 Aug; 41(7):817-20. PubMed ID: 2886875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.